POM-V Prescription Required

Cevac Salmune ETI K Suspension for Injection for Chickens

Active ingredient: Salmonella enterica subsp. enterica

Form

Injection

Species

Chickens

Manufacturer

Ceva-Phylaxia Veterinary Biologicals Co. Ltd

VMD MA No.

EU/2/24/320/001-002

What it's used for

Salmonella Enteritidis: Onset of immunity: 4 weeks after 2nd vaccination Duration of immunity: 69 weeks after 2nd vaccination Salmonella Typhimurium: Onset...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Salmonella enterica subsp. e...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Cevac Salmune ETI K Suspension for Injection for Chickens — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Salmonella Enteritidis:
Onset of immunity: 4 weeks after 2nd vaccination
Duration of immunity: 69 weeks after 2nd vaccination
Salmonella Typhimurium:
Onset of immunity: 4 weeks after 2nd vaccination
Duration of immunity: 71 weeks after 2nd vaccination
Salmonella Infantis:
Onset of immunity: 4 weeks after 2nd vaccination
Duration of immunity: 44 weeks after 2nd vaccination

Two vaccinations into breast muscle, each of 0.5 ml, with an interval of four weeks
should be given.
The recommended age for the first vaccination is from 10 weeks. Second
vaccination should be given no later than 4 weeks before the onset of lay.
Shake well before use.
Apply usual aseptic procedures.

None.

Chickens:
Very common (>1 animal/10 treated):Injection site reaction*
*Yellow discolouration in breast muscle four weeks after the second vaccination.
AN: 00488//2023
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or the national competent authority via
the national reporting system. See the package leaflet for respective contact details.

Vaccinate healthy animals only.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product, therefore, needs to be made on a case-by-
case basis.

Store and transport refrigerated (2 °C – 8 °C).
Do not freeze.
Protect from light.

Zero days.
AN: 00488//2023

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.